GlobeNewswire by notified

Solutions 30 : MARKET INFORMATION AND RESUMPTION OF TRADING ON MONDAY, MAY 24, 2021

Share

MARKET INFORMATION AND RESUMPTION OF TRADING ON MONDAY, MAY 24, 2021

During the Audit Committee meeting held on May 20, 2021, EY, Solutions 30’s auditor, informed the company that it was not in a position to express an opinion on its 2020 financial statements, without however submitting its final report which incorporates the basis of this impossibility to express an opinion. At the time of this press release, the final audit report was not available.

In the meantime, the Supervisory Board meeting on May 20, 2021, took note of EY’s position and confirmed the main 2020 financial aggregates, already communicated on April 28, 2021, which remain unchanged:

  1. 2020 revenue came in at €819.3 million, up 18%
  2. EBITDA is €106.5 million
  3. Adjusted EBIT is €60.9 million
  4. A net cash surplus of €59.2 million

The group’s net income amounted to €34.5 million, after taking into account a correction proposed by the company and relating to the recognition of an additional tax expense of €2.4 million. In the first quarter of 2021, revenue grew by 19% to €225.2 million.

Action plan

The Management Board, in agreement with the Supervisory Board, has taken the following decisions in the interests of the group and its stakeholders:

  1. The annual general meeting of shareholders is scheduled for June 30, 2021, the regulatory deadline. The preparatory documents for this meeting will therefore be made available to shareholders on May 31st.
  2. The group’s annual report will be published after receiving EY’s final audit report. As a result, the company is still unable to provide a precise timetable for the publication of this report.
  3. The company is considering the possibility of appointing a new auditor.

EY’s assertion that it is not in a position to express an opinion is unusual in that it does not constitute an unqualified, a qualified, or an adverse opinion.

This is a paradoxical situation for Solutions 30 since:

  1. The company has a solid financial structure and a business model that has enabled it to finance its growth, while keeping its level of debt largely under control, as evidenced by its cash position of €159 million in its bank accounts that are carried on its balance sheet at December 31, 2020.
  2. Every year since 2005, the company’s financial statements have received an unqualified opinion from its auditors, in particular from EY for fiscal 2019, the year IFRS was adopted, and for the review of the half-yearly financial statements at June 30, 2020.
  3. The conclusions of the independent investigations carried out by Deloitte and Didier Kling Expertise & Conseil have confirmed the financial information from previous years communicated by the company, in particular its level of growth, its margin rates, the level and nature of its bank debt, the accounting treatment and the level of invoices to be issued, software development costs, negative goodwill, and non-operating income.

Faced with the possible consequences of this disclaimer of opinion, the group decided to refer the matter to the President of the Commercial Court of Bobigny for the purpose of requesting that a conciliator be appointed to assist it and in doing so anticipate the answers or solutions needed to ensure the support of the group’s partners.

At the same time, Solutions 30 has initiated a selection process for investment bankers in order to start searching for reference shareholders. The project, which the company does not intend to comment on beyond its legal obligations to do so, could go as far as a delisting.

A group positioned in high-growth markets

Positioned in fast-growing markets, the group employs 15,700 people in 10 European countries. Its customers include the largest companies and groups in Europe in the telecoms, energy, and IT sectors.  Its job is extremely tangible: deploying optical fiber, connecting homes to the Internet, installing smart electricity meters, or providing IT assistance to individuals and companies.

Building on its recent commercial successes across Europe, notably in Italy and Spain with broadband Internet deployments and in Belgium with the installation of smart meters, Solutions 30 and all its teams are focused on delivering the best service to their customers to support the digital transformation and the energy transition.

Resumption of trading

Despite the absence of an annual financial report and a precise timetable for its publication, the company has asked Euronext Paris to resume the listing of its shares (FR0013379484) as of the opening of trading on Monday, May 24th.

About Solutions 30 SE

The Solutions 30 group is the European leader in solutions for new technologies. Its mission is to make the technological developments that are transforming our daily lives accessible to everyone, individuals and businesses alike. Yesterday, it was computers and the Internet. Today, it’s digital technology. Tomorrow, it will be technologies that make the world even more interconnected in real time. With more than 30 million call-outs carried out since it was founded and a network of more than 15,700 local technicians, Solutions 30 currently covers all of France, Italy, Germany, the Netherlands, Belgium, Luxembourg, the Iberian Peninsula, the United Kingdom, and Poland. The share capital of Solutions 30 SE consists of 107,127,984 shares, equal to the number of theoretical votes that can be exercised.
Solutions 30 SE is listed on the Euronext Paris exchange (ISIN FR0013379484- code S30). Indexes: MSCI Europe Small Cap | Tech40 | CAC PME | SBF120 | CAC Mid 60. Visit our website for more information: www.solutions30.com

Contact

Individual shareholders       Investor relations           |  Tel: +33 1 86 86 00 63       | actionnaires@solutions30.com

Analysts/investors                Nathalie Boumendil       |  Tel: +33 6 85 82 41 95       |  nathalie.boumendil@solutions30.com

Press - Image 7                  Leslie Jung                    |  Tel: +44 7818 641803         |  ljung@image7.fr

                                            Flore Larger                  |  Tel: +33 6 33 13 41 50       |  flarger@image7.fr
                                            Charlotte Le Barbier     |  Tel: +33 6 78 37 27 60       |  clebarbier@image7.fr

Attachment

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Sodexo announces solid H1 Fiscal 2024 results19.4.2024 07:00:00 CEST | Press release

Issy-les-Moulineaux, April 19, 2024 Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY) Sodexo announces solid H1 Fiscal 2024 results Organic Revenue growth +8.5%Underlying operating profit +16.9% at constant currencies, margin up +40 bpsFiscal 2024 guidance:Organic growth now expected at the top of the +6% to +8% rangeUnderlying operating profit margin improvement confirmed at +30 to +40 bps, at constant currencies At the Board of Directors meeting held on April 18, 2024, chaired by Sophie Bellon, the Board closed the Consolidated accounts for the First half Fiscal 2024 ended February 29, 2024. First half Fiscal 2024 key figures (in million euros)H1 FISCAL 2024H1 FISCAL 2023 RESTATEDDIFFERENCEDIFFERENCE CONSTANT RATESRevenues12,10111,581 +4.5% +7.8%Organic revenue growth +8.5% +12.9%UNDERLYING OPERATING PROFIT612545+12.3%+16.9%UNDERLYING OPERATING PROFIT MARGIN5.1%4.7%+40bps+40bpsOther operating income & expenses30(36)OPERATING PROFIT642509+26.1%+30.1%Net financial expense(46)(43)Tax cha

Pluxee delivers strong performance in the First Half and raises Fiscal 2024 Organic revenue growth and Recurring EBITDA margin objectives19.4.2024 07:00:00 CEST | Press release

First Half Fiscal 2024 Results Issy-les-Moulineaux, France – April 19, 2024 First Half Fiscal 2024 highlights Successful spin-off and listing on Euronext Paris on February 1, 2024 Organic revenue growth of +24% incl. +26% in Q2, reflecting buoyant performance across all regions Strong Recurring EBITDA at €201 million, i.e. +28% organic growth; 34.4% margin at constant rates Net profit of €68 million reflecting higher one-time items, mostly spin-off related Recurring free cash flow of €228 million, with strong Recurring Cash conversion of 113%Net cash position of €1,065 million, increasing by €206 million since August 31, 2023Fiscal 2024 financial objectives raised: Organic revenue growth expected between 15% to 17% and Recurring EBITDA margin expected at 35% at least including standalone costs at constant rates, while reaffirming all mid-term targets First Half Fiscal 2024 key figures (in millions of euros)H1 FY 2024H1 FY 2023Variation (%)Variation at constant rate (%)Total revenues593

FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer19.4.2024 07:00:00 CEST | Press release

Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented 76% in people with ALK-positive early-stage resected non-small cell lung cancer (NSCLC)1This approval helps address an urgent unmet need, with about half of people living with early-stage NSCLC experiencing disease recurrence following surgery, despite adjuvant chemotherapy2The National Comprehensive Cancer Network® (NCCN®) Guidelines recommend routine testing for ALK, EGFR and PD-L1 biomarkers in people with early-stage NSCLC to inform adjuvant therapy selection Basel, 19 April 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumour resection for patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) (tumours ≥ 4 cm or node positive), as detected by an FDA-approved test. Alecensa is now the first and on

Evs Invites Its Shareholders to the Ordinary General Meeting and an Extraordinary General Meeting on May 21, 202419.4.2024 06:30:00 CEST | Press release

Publication on April 19, 2024, at 6:30 am before market opening Regulated information EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS INVITES ITS SHAREHOLDERS TO THE ORDINARY GENERAL MEETING AND AN EXTRAORDINARY GENERAL MEETING ON MAY 21, 2024 EVS Broadcast Equipment, leading provider of live video production systems, published today the invitation to its Ordinary General Meeting, to be held on May 21, 2024, at 11 am, at its registered office in Liège, to deliberate on the agenda available on the website of the company (see link below). Aside from the usual topics, including the 2023 annual and sustainability reports, the Board of Directors will propose to the Shareholders to approve the following resolutions: The payment of a total gross dividend of EUR 1.10 per share (including the interim dividend of EUR 0.50 paid in November 2023);A profit-sharing plan in the form of a grant of 36 EVS shares for each EVS employee, in proportion to

Icelandic Salmon - Annual Report for 202319.4.2024 06:00:00 CEST | Press release

Bíldudalur, 19 April 2023 Icelandic Salmon AS (Euronext Growth Oslo and First North Iceland: ISLAX) has today published its integrated Annual Report for 2023, including sustainability reporting and complete annual accounts with notes. The report is attached and available on the company‘s website: https://arnarlax.is/investors/ “In 2023, Icelandic Salmon supplied the world markets with a record-breaking 17,919 tonnes of salmon, thanks to the dedicated work of our employees. Despite facing many challenges this year - including macroeconomic changes, geopolitical tensions, and biological obstacles – we prioritised the health and wellbeing of our fish. Looking ahead, we are committed to sustaining this priority while growing our operations," Bjørn Hembre, CEO of Icelandic Salmon and Arnarlax says. In Bjørn‘s letter, which in included in the report, he writes: “Salmon farming holds great promise for Iceland, in terms of future jobs and economic growth. During the past few years, we have see

HiddenA line styled icon from Orion Icon Library.Eye